{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:16:32Z","timestamp":1740114992255,"version":"3.37.3"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903613"],"award-info":[{"award-number":["81903613"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.tox.2024.153916","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T19:30:20Z","timestamp":1723491020000},"page":"153916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Investigating the cardiotoxicity of N-n-butyl haloperidol iodide: Inhibition mechanisms on hERG channels"],"prefix":"10.1016","volume":"508","author":[{"given":"Jilin","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingxuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbo","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binger","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenfei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2024.153916_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0092-8674(00)80728-X","article-title":"MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia","volume":"97","author":"Abbott","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.tox.2024.153916_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.138996","article-title":"Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: a global health emergency","volume":"730","author":"Acter","year":"2020","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.tox.2024.153916_bib3","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.1021\/jm060500o","article-title":"Common pharmacophores for uncharged human ether-a-go-go-related gene (hERG) blockers","volume":"49","author":"Aronov","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tox.2024.153916_bib4","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.bmc.2004.02.003","article-title":"A model for identifying HERG K+ channel blockers","volume":"12","author":"Aronov","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.tox.2024.153916_bib5","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/cts.12674","article-title":"Clinical trial in a dish: personalized stem cell-derived cardiomyocyte assay compared with clinical trial results for two qt-prolonging drugs","volume":"12","author":"Blinova","year":"2019","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.tox.2024.153916_bib6","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1021\/bi200173n","article-title":"Computer simulations of structure-activity relationships for HERG channel blockers","volume":"50","author":"Boukharta","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.tox.2024.153916_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00002018-200023030-00004","article-title":"Cardiovascular adverse effects of antipsychotic drugs","volume":"23","author":"Buckley","year":"2000","journal-title":"Drug Saf."},{"key":"10.1016\/j.tox.2024.153916_bib8","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jmb.2010.06.040","article-title":"Structural and dynamic determinants of ligand binding and regulation of cyclin-dependent kinase 5 by pathological activator p25 and inhibitory peptide CIP","volume":"401","author":"Cardone","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.tox.2024.153916_bib9","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1039\/C4CP00110A","article-title":"NMR mapping of protein conformational landscapes using coordinated behavior of chemical shifts upon ligand binding","volume":"16","author":"Cembran","year":"2014","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.tox.2024.153916_bib10","article-title":"The antihistamine fexofenadine does not affect I(Kr) currents in a case report of drug-induced cardiac arrhythmia","volume":"137","author":"Cr","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tox.2024.153916_bib11","article-title":"Molecular basis of hERG potassium channel blockade by the class Ic antiarrhythmic flecainide","volume":"86","author":"D","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.tox.2024.153916_bib12","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1745-7254.2007.00562.x","article-title":"Verapamil blocks HERG channel by the helix residue Y652 and F656 in the S6 transmembrane domain","volume":"28","author":"Duan","year":"2007","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.tox.2024.153916_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105264","article-title":"Quinazolinone dimers as a potential new class of safer Kv1 inhibitors: overcoming hERG, sodium and calcium channel affinities","volume":"115","author":"Emam","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.tox.2024.153916_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrd1108","article-title":"The impact of drug-induced QT interval prolongation on drug discovery and development","volume":"2","author":"Fermini","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tox.2024.153916_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/bja\/aeh026","article-title":"Local anaesthetic sensitivities of cloned HERG channels from human heart: comparison with HERG\/MiRP1 and HERG\/MiRP1 T8A","volume":"92","author":"Friederich","year":"2004","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.tox.2024.153916_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2020.116082","article-title":"Application of electrophysiological technique in toxicological study: from manual to automated patch-clamp recording","volume":"133","author":"Gao","year":"2020","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.tox.2024.153916_bib17","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1176\/appi.ajp.2013.12060860","article-title":"Drug-induced long QT in adult psychiatric inpatients: the 5-year cross-sectional ECG Screening Outcome in Psychiatry study","volume":"170","author":"Girardin","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.tox.2024.153916_bib18","doi-asserted-by":"crossref","unstructured":"Hancox, J.C., McPate, M.J., El Harchi, A., Zhang, Y. hong, 2008. The hERG potassium channel and hERG screening for drug-induced torsades de pointes. Pharmacology & Therapeutics, Models and issues in drug-induced torsades de pointes liability testing 119, 118\u2013132. https:\/\/doi.org\/10.1016\/j.pharmthera.2008.05.009.","DOI":"10.1016\/j.pharmthera.2008.05.009"},{"key":"10.1016\/j.tox.2024.153916_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/096032719101000110","article-title":"Life-threatening ventricular arrhythmia (torsades de pointes) after haloperidol overdose","volume":"10","author":"Henderson","year":"1991","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.tox.2024.153916_bib20","doi-asserted-by":"crossref","unstructured":"Kaminski, G.A., Friesner, R.A., Tirado-Rives, J., Jorgensen, W.L., n.d. Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides. \u3008https:\/\/doi.org\/10.1021\/jp003919d\u3009.","DOI":"10.1021\/jp003919d"},{"key":"10.1016\/j.tox.2024.153916_bib21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1124\/mol.60.2.244","article-title":"Open channel block of HERG K(+) channels by vesnarinone","volume":"60","author":"Kamiya","year":"2001","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.tox.2024.153916_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1254\/jphs.08102FP","article-title":"Molecular determinants of hERG channel block by terfenadine and cisapride","volume":"108","author":"Kamiya","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tox.2024.153916_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153706","article-title":"Combination of curcumin with N-n-butyl haloperidol iodide inhibits hepatocellular carcinoma malignant proliferation by downregulating enhancer of zeste homolog 2 (EZH2) - lncRNA H19 to silence Wnt\/\u03b2-catenin signaling","volume":"91","author":"Khan","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.tox.2024.153916_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-2999(02)02074-5","article-title":"A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs","volume":"450","author":"Kongsamut","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tox.2024.153916_bib25","first-page":"367","article-title":"Molecular determinant of high-affinity dofetilide binding to HERG1 expressed in Xenopus oocytes: involvement of S6 sites","volume":"57","author":"Lees-Miller","year":"2000","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.tox.2024.153916_bib26","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.bpj.2019.07.029","article-title":"Rapid characterization of hERG channel kinetics I: using an automated high-throughput system","volume":"117","author":"Lei","year":"2019","journal-title":"Biophys. J."},{"key":"10.1016\/j.tox.2024.153916_bib27","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/FJC.0000000000001550","article-title":"N -N-Butyl haloperidol iodide mitigates myocardial ischemia\/reperfusion injury through activation of SIRT1-Nrf2 signaling loop","volume":"83","author":"Lu","year":"2024","journal-title":"J. Cardiovasc Pharm."},{"key":"10.1016\/j.tox.2024.153916_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18049","article-title":"N-n-butyl haloperidol iodide mediates cardioprotection via regulating AMPK\/FoxO1 signalling","volume":"28","author":"Lu","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.tox.2024.153916_bib29","first-page":"520","article-title":"N-n-butyl haloperidol iodide protects against hypoxia\/reoxygenation injury in cardiac microvascular endothelial cells by regulating the ROS\/MAPK\/Egr-1 pathway","volume":"7","author":"Lu","year":"2016","journal-title":"Front Pharm."},{"key":"10.1016\/j.tox.2024.153916_bib30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/jcc.20842","article-title":"Modeling the hERG potassium channel in a phospholipid bilayer: molecular dynamics and drug docking studies","volume":"29","author":"Masetti","year":"2008","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.tox.2024.153916_bib31","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00004714-199304000-00007","article-title":"Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill","volume":"13","author":"Metzger","year":"1993","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.tox.2024.153916_bib32","doi-asserted-by":"crossref","first-page":"12329","DOI":"10.1073\/pnas.210244497","article-title":"A structural basis for drug-induced long QT syndrome","volume":"97","author":"Mitcheson","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tox.2024.153916_bib33","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.RES.87.11.1012","article-title":"Probing the interaction between inactivation gating and Dd-sotalol block of HERG","volume":"87","author":"Numaguchi","year":"2000","journal-title":"Circ. Res"},{"key":"10.1016\/j.tox.2024.153916_bib34","doi-asserted-by":"crossref","first-page":"12491","DOI":"10.1080\/07391102.2021.1971561","article-title":"Evaluation of flavonoids from banana pseudostem and flower (quercetin and catechin) as potent inhibitors of \u03b1-glucosidase: an in silico perspective","volume":"40","author":"Patil","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.tox.2024.153916_bib35","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1016\/j.bmcl.2004.03.057","article-title":"Pharmacophore-based search, synthesis, and biological evaluation of anthranilic amides as novel blockers of the Kv1.5 channel","volume":"14","author":"Peukert","year":"2004","journal-title":"Bioorg. Med Chem. Lett."},{"key":"10.1016\/j.tox.2024.153916_bib36","article-title":"Drug block of the hERG potassium channel: insight from modeling","volume":"68","author":"Pj","year":"2007","journal-title":"Proteins"},{"key":"10.1016\/j.tox.2024.153916_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081208","article-title":"Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe","volume":"8","author":"Raschi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tox.2024.153916_bib38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.tox.2024.153916_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.114961","article-title":"A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigm","volume":"394","author":"Ridder","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2024.153916_bib40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.vascn.2015.08.032","article-title":"The source of hERG IC50 values (manual vs. automated patch clamp) may influence in silico modeling","volume":"75","author":"Rohrbacher","year":"2015","journal-title":"J. Pharmacol. Toxicol. Methods Focus. Issue Saf. Pharmacol."},{"key":"10.1016\/j.tox.2024.153916_bib41","doi-asserted-by":"crossref","first-page":"23587","DOI":"10.1074\/jbc.M200448200","article-title":"Molecular determinants of voltage-dependent human ether-a-go-go related gene (HERG) K+ channel block","volume":"277","author":"S\u00e1nchez-Chapula","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tox.2024.153916_bib42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tips.2005.01.003","article-title":"Predicting drug-hERG channel interactions that cause acquired long QT syndrome","volume":"26","author":"Sanguinetti","year":"2005","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.tox.2024.153916_bib43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature04710","article-title":"hERG potassium channels and cardiac arrhythmia","volume":"440","author":"Sanguinetti","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.tox.2024.153916_bib44","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1747-0285.2006.00379.x","article-title":"A QSAR model of HERG binding using a large, diverse, and internally consistent training set","volume":"67","author":"Seierstad","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.tox.2024.153916_bib45","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1073\/pnas.180223197","article-title":"A common polymorphism associated with antibiotic-induced cardiac arrhythmia","volume":"97","author":"Sesti","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tox.2024.153916_bib46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41401-021-00630-7","article-title":"N-n-Butyl haloperidol iodide ameliorates liver fibrosis and hepatic stellate cell activation in mice","volume":"43","author":"Shen","year":"2022","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.tox.2024.153916_bib47","first-page":"142","article-title":"Effect of haloperidol on the strips of porcine coronary artery","volume":"3","author":"Shi","year":"1996","journal-title":"Chin. Pharm. J."},{"key":"10.1016\/j.tox.2024.153916_bib48","first-page":"33","article-title":"Analysis of 5 case of treating unstable angina patients with haloperidol","volume":"2","author":"Shi","year":"1997","journal-title":"J. Shantou Univ. Med Coll."},{"key":"10.1016\/j.tox.2024.153916_bib49","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40264-013-0016-z","article-title":"Dealing with global safety issues: was the response to QT-liability of non-cardiac drugs well coordinated?","volume":"36","author":"Stockbridge","year":"2013","journal-title":"Drug Saf."},{"issue":"105","key":"10.1016\/j.tox.2024.153916_bib50","article-title":"Reliable identification of hERG liability in drug discovery by automated patch clamp","volume":"2020","author":"Stoelzle-Feix","year":"2020","journal-title":"J. Pharmacol. Toxicol. Methods, Saf. Pharmacol."},{"key":"10.1016\/j.tox.2024.153916_bib51","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/sj.bjp.0700989","article-title":"The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes","volume":"120","author":"Suessbrich","year":"1997","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.tox.2024.153916_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fphar.2018.00019","article-title":"N-n-Butyl haloperidol iodide, a derivative of the anti-psychotic haloperidol, antagonizes hypoxia\/reoxygenation injury by inhibiting an Egr-1\/ROS positive feedback loop in H9c2 cells","volume":"9","author":"Sun","year":"2018","journal-title":"Front. Pharm."},{"key":"10.1016\/j.tox.2024.153916_bib53","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00894-011-1136-y","article-title":"Predicting the potency of hERG K+ channel inhibition by combining 3D-QSAR pharmacophore and 2D-QSAR models","volume":"18","author":"Tan","year":"2012","journal-title":"J. Mol. Model"},{"key":"10.1016\/j.tox.2024.153916_bib54","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1124\/jpet.300.2.543","article-title":"The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels","volume":"300","author":"Thomas","year":"2002","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.tox.2024.153916_bib55","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.tips.2017.06.004","article-title":"Towards a structural view of drug binding to hERG K+ channels","volume":"38","author":"Vandenberg","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tox.2024.153916_bib56","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1152\/physrev.00036.2011","article-title":"hERG K(+) channels: structure, function, and clinical significance","volume":"92","author":"Vandenberg","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tox.2024.153916_bib57","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cell.2017.03.048","article-title":"Cryo-EM structure of the open human ether-\u00e0-go-go-related K+ channel hERG","volume":"169","author":"Wang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tox.2024.153916_bib58","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1111\/jcmm.16292","article-title":"Rutaecarpine targets hERG channels and participates in regulating electrophysiological properties leading to ventricular arrhythmia","volume":"25","author":"Zhan","year":"2021","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.tox.2024.153916_bib59","article-title":"Effect of N-n-butyl haloperidol iodide on ROS\/JNK\/Egr-1 signaling in H9c2 cells after hypoxia\/reoxygenation","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci. Rep."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X24001975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X24001975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T16:54:04Z","timestamp":1732640044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X24001975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":59,"alternative-id":["S0300483X24001975"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2024.153916","relation":{},"ISSN":["0300-483X"],"issn-type":[{"type":"print","value":"0300-483X"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating the cardiotoxicity of N-n-butyl haloperidol iodide: Inhibition mechanisms on hERG channels","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2024.153916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"153916"}}